Central Nervous System Stimulant [EPC]

Central Nervous System Stimulant [EPC] was reported 189360 times

These side effects are most commonly reported by patients taking drugs of the Central Nervous System Stimulant [EPC] class:

# Drug class Count
0 DRUG INEFFECTIVE 17587
1 OFF LABEL USE 15321
2 FATIGUE 13337
3 PAIN 12212
4 NAUSEA 11917
5 HEADACHE 11750
6 ARTHRALGIA 9040
7 TOXICITY TO VARIOUS AGENTS 8945
8 DYSPNOEA 8914
9 PYREXIA 8332
10 VOMITING 8124
11 DIARRHOEA 8044
12 RASH 7514
13 COMPLETED SUICIDE 7331
14 NO ADVERSE EVENT 7039
15 DIZZINESS 6508
16 DEATH 6403
17 INFUSION RELATED REACTION 6285
18 PRODUCT QUALITY ISSUE 5971
19 MALAISE 5949
20 ASTHENIA 5843
21 PNEUMONIA 5822
22 FALL 5766
23 PRURITUS 5684
24 CONDITION AGGRAVATED 5612
25 WEIGHT INCREASED 5455
26 SINUSITIS 5399
27 HYPOTENSION 5144
28 JOINT SWELLING 5112
29 NASOPHARYNGITIS 5035
30 RHEUMATOID ARTHRITIS 5001
31 WEIGHT DECREASED 4989
32 OVERDOSE 4810
33 PAIN IN EXTREMITY 4689
34 ANXIETY 4684
35 HYPERTENSION 4651
36 HYPERSENSITIVITY 4602
37 ABDOMINAL PAIN 4583
38 BLOOD PRESSURE INCREASED 4569
39 COUGH 4562
40 INSOMNIA 4548
41 BACK PAIN 4462
42 CONFUSIONAL STATE 4209
43 PERIPHERAL SWELLING 4129
44 ACUTE KIDNEY INJURY 4022
45 SOMNOLENCE 3957
46 ABDOMINAL DISCOMFORT 3915
47 ABDOMINAL PAIN UPPER 3799
48 SWELLING 3780
49 DRUG INTOLERANCE 3759
50 DECREASED APPETITE 3683
51 DEPRESSION 3675
52 ALOPECIA 3624
53 URINARY TRACT INFECTION 3573
54 CHRONIC KIDNEY DISEASE 3557
55 INFECTION 3529
56 CONSTIPATION 3519
57 RENAL FAILURE 3268
58 CHEST PAIN 3256
59 HEPATIC ENZYME INCREASED 3255
60 INTENTIONAL PRODUCT USE ISSUE 3164
61 ANAEMIA 3128
62 PRODUCT USE IN UNAPPROVED INDICATION 3042
63 DRUG HYPERSENSITIVITY 2985
64 ARTHROPATHY 2970
65 DRUG INTERACTION 2966
66 PRODUCT USE ISSUE 2894
67 LOWER RESPIRATORY TRACT INFECTION 2802
68 URTICARIA 2789
69 FEELING ABNORMAL 2730
70 THERAPEUTIC PRODUCT EFFECT DECREASED 2719
71 GAIT DISTURBANCE 2687
72 SYNOVITIS 2590
73 CONTRAINDICATED PRODUCT ADMINISTERED 2517
74 BLOOD PRESSURE FLUCTUATION 2514
75 MIGRAINE 2508
76 HEART RATE INCREASED 2483
77 ERYTHEMA 2480
78 OXYGEN SATURATION DECREASED 2476
79 CONTUSION 2470
80 DRUG ABUSE 2470
81 DISCOMFORT 2452
82 GASTROINTESTINAL DISORDER 2451
83 BLISTER 2437
84 INTENTIONAL OVERDOSE 2427
85 HYPOAESTHESIA 2394
86 CHILLS 2373
87 GENERAL PHYSICAL HEALTH DETERIORATION 2360
88 MUSCULOSKELETAL STIFFNESS 2347
89 STOMATITIS 2321
90 TREMOR 2314
91 DRUG ADMINISTRATION ERROR 2286
92 SEPSIS 2261
93 DEHYDRATION 2245
94 SYSTEMIC LUPUS ERYTHEMATOSUS 2239
95 TACHYCARDIA 2230
96 WOUND 2225
97 HAEMOGLOBIN DECREASED 2216
98 HAND DEFORMITY 2175
99 DRUG DOSE OMISSION 2142
100 HYPERHIDROSIS 2130
101 OEDEMA PERIPHERAL 2126
102 MUSCLE SPASMS 2094
103 GLOSSODYNIA 2093
104 PERICARDITIS 2088
105 PEMPHIGUS 2068
106 CARDIAC ARREST 2045
107 MYALGIA 2044
108 WRONG TECHNIQUE IN DRUG USAGE PROCESS 2040
109 ALANINE AMINOTRANSFERASE INCREASED 1968
110 HEART RATE DECREASED 1962
111 MATERNAL EXPOSURE DURING PREGNANCY 1962
112 PARAESTHESIA 1944
113 BRONCHITIS 1937
114 ILL-DEFINED DISORDER 1935
115 IMPAIRED HEALING 1914
116 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1912
117 INFLUENZA 1905
118 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 1904
119 LOSS OF CONSCIOUSNESS 1836
120 IRRITABLE BOWEL SYNDROME 1823
121 MOBILITY DECREASED 1814
122 THROMBOCYTOPENIA 1807
123 TREATMENT FAILURE 1785
124 MUSCULAR WEAKNESS 1774
125 INCORRECT DOSE ADMINISTERED 1764
126 CHEST DISCOMFORT 1754
127 NEUTROPENIA 1741
128 FEBRILE NEUTROPENIA 1715
129 CARDIO-RESPIRATORY ARREST 1702
130 ATRIAL FIBRILLATION 1693
131 PALPITATIONS 1693
132 APPLICATION SITE ERYTHEMA 1665
133 BLOOD PRESSURE SYSTOLIC INCREASED 1660
134 AGITATION 1654
135 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1647
136 HELICOBACTER INFECTION 1638
137 OROPHARYNGEAL PAIN 1635
138 BALANCE DISORDER 1631
139 PULMONARY EMBOLISM 1627
140 ASPARTATE AMINOTRANSFERASE INCREASED 1603
141 GASTROOESOPHAGEAL REFLUX DISEASE 1591
142 SUICIDE ATTEMPT 1583
143 PLATELET COUNT DECREASED 1570
144 SYNCOPE 1570
145 INCORRECT DRUG ADMINISTRATION DURATION 1564
146 DEPRESSED LEVEL OF CONSCIOUSNESS 1563
147 FOLLICULITIS 1553
148 METABOLIC ACIDOSIS 1544
149 DUODENAL ULCER PERFORATION 1543
150 ARTHRITIS 1536
151 COVID-19 1530
152 WHITE BLOOD CELL COUNT DECREASED 1527
153 INTENTIONAL PRODUCT MISUSE 1522
154 MUSCLE INJURY 1518
155 DYSPEPSIA 1514
156 CEREBROVASCULAR ACCIDENT 1510
157 FLUSHING 1503
158 BLOOD CREATININE INCREASED 1493
159 VISION BLURRED 1490
160 DISTURBANCE IN ATTENTION 1481
161 DYSPHAGIA 1448
162 MYOCARDIAL INFARCTION 1431
163 MEMORY IMPAIRMENT 1401
164 ABDOMINAL DISTENSION 1381
165 DRUG DEPENDENCE 1379
166 RESPIRATORY FAILURE 1379
167 MEDICATION ERROR 1376
168 INJURY 1362
169 ASTHMA 1358
170 ACUTE HEPATIC FAILURE 1334
171 UPPER RESPIRATORY TRACT INFECTION 1305
172 EMOTIONAL DISTRESS 1295
173 PRODUCT DOSE OMISSION ISSUE 1270
174 BLOOD CHOLESTEROL INCREASED 1265
175 STRESS 1262
176 RENAL FAILURE ACUTE 1261
177 COMA 1253
178 BLOOD PRESSURE DECREASED 1252
179 INFLAMMATION 1246
180 PLEURAL EFFUSION 1233
181 SLEEP DISORDER 1229
182 SUICIDAL IDEATION 1222
183 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 1212
184 HERPES ZOSTER 1211
185 SEIZURE 1208
186 HEPATOTOXICITY 1202
187 DRUG TOXICITY 1200
188 MUSCULOSKELETAL PAIN 1200
189 CELLULITIS 1199
190 BODY TEMPERATURE INCREASED 1187
191 GASTROINTESTINAL HAEMORRHAGE 1184
192 COGNITIVE DISORDER 1176
193 HYPONATRAEMIA 1174
194 BLOOD GLUCOSE INCREASED 1166
195 DRUG PRESCRIBING ERROR 1166
196 C-REACTIVE PROTEIN INCREASED 1155
197 OSTEOARTHRITIS 1154
198 RESPIRATORY ARREST 1144
199 END STAGE RENAL DISEASE 1143
200 DEEP VEIN THROMBOSIS 1129
201 BRADYCARDIA 1127
202 DRY MOUTH 1127
203 PULMONARY OEDEMA 1124
204 NECK PAIN 1120
205 NEUROPATHY PERIPHERAL 1116
206 VISUAL IMPAIRMENT 1113
207 RENAL IMPAIRMENT 1102
208 AGGRESSION 1097
209 INFLUENZA LIKE ILLNESS 1084
210 INJECTION SITE PAIN 1078
211 LETHARGY 1069
212 HEPATIC FAILURE 1055
213 RHEUMATOID FACTOR POSITIVE 1045
214 INTERNATIONAL NORMALISED RATIO INCREASED 1044
215 EXPOSURE DURING PREGNANCY 1039
216 HALLUCINATION 1023
217 HYPOKALAEMIA 1012
218 WHEEZING 1012
219 OEDEMA 1005
220 DISEASE PROGRESSION 1001
221 CATARACT 991
222 NASAL CONGESTION 978
223 EPISTAXIS 974
224 THROAT IRRITATION 974
225 HAEMORRHAGE 971
226 FIBROMYALGIA 962
227 THROMBOSIS 954
228 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 945
229 PRODUCTIVE COUGH 936
230 NIGHT SWEATS 928
231 ADVERSE DRUG REACTION 924
232 ABNORMAL BEHAVIOUR 920
233 HYPOXIA 920
234 OSTEOPOROSIS 919
235 RHINORRHOEA 917
236 LIVER INJURY 916
237 IRRITABILITY 914
238 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 912
239 FEELING HOT 908
240 PANCYTOPENIA 907
241 CARDIAC FAILURE CONGESTIVE 905
242 NEPHROLITHIASIS 904
243 BLOOD PRESSURE DIASTOLIC ABNORMAL 897
244 AMNESIA 895
245 CONVULSION 889
246 HOSPITALISATION 887
247 ANAPHYLACTIC REACTION 875
248 SEDATION 868
249 RENAL INJURY 864
250 CARDIAC FAILURE 860
251 UNEVALUABLE EVENT 852
252 THERAPEUTIC RESPONSE UNEXPECTED 848
253 VERTIGO 845
254 HOT FLUSH 838
255 DELIRIUM 835
256 HEART RATE IRREGULAR 835
257 BLOOD PRESSURE DIASTOLIC DECREASED 834
258 CARDIAC DISORDER 829
259 HYPOGLYCAEMIA 829
260 APPLICATION SITE PRURITUS 828
261 DIABETES MELLITUS 826
262 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 824
263 CYSTITIS 824
264 TYPE 2 DIABETES MELLITUS 823
265 EAR PAIN 814
266 RECTAL HAEMORRHAGE 814
267 UNDERDOSE 811
268 SWELLING FACE 807
269 UNRESPONSIVE TO STIMULI 804
270 COAGULOPATHY 802
271 ACCIDENTAL OVERDOSE 801
272 ADVERSE EVENT 801
273 RESPIRATORY DISORDER 800
274 DEPRESSED MOOD 798
275 LUNG DISORDER 786
276 LEUKOPENIA 783
277 MALIGNANT NEOPLASM PROGRESSION 783
278 ORTHOSTATIC HYPOTENSION 777
279 CHOLELITHIASIS 771
280 MENTAL STATUS CHANGES 768
281 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 767
282 INTENTIONAL DRUG MISUSE 765
283 WHITE BLOOD CELL COUNT INCREASED 765
284 LIVER FUNCTION TEST ABNORMAL 760
285 HAEMATOCHEZIA 757
286 FOETAL EXPOSURE DURING PREGNANCY 752
287 EAR INFECTION 747
288 BODY TEMPERATURE DECREASED 746
289 LIVER DISORDER 743
290 SLEEP APNOEA SYNDROME 741
291 BURNING SENSATION 735
292 ILLNESS 730
293 PRODUCT ADHESION ISSUE 729
294 SEPTIC SHOCK 726
295 DRUG ADMINISTERED AT INAPPROPRIATE SITE 721
296 BONE PAIN 718
297 HAEMATOCRIT DECREASED 718
298 ENCEPHALOPATHY 714
299 RHABDOMYOLYSIS 708
300 BLOOD ALKALINE PHOSPHATASE INCREASED 700
301 BLOOD PRESSURE SYSTOLIC ABNORMAL 699
302 DYSKINESIA 695
303 PSYCHOMOTOR HYPERACTIVITY 694
304 DRUG-INDUCED LIVER INJURY 691
305 BLOOD BILIRUBIN INCREASED 688
306 ROAD TRAFFIC ACCIDENT 683
307 RASH ERYTHEMATOUS 680
308 SPEECH DISORDER 676
309 MULTIPLE SCLEROSIS RELAPSE 673
310 NERVOUSNESS 671
311 FLUID RETENTION 668
312 THERAPEUTIC RESPONSE DECREASED 667
313 DRUG EFFECT DECREASED 666
314 RESTLESSNESS 661
315 RESPIRATORY DISTRESS 655
316 ARRHYTHMIA 653
317 LYMPHOCYTE COUNT DECREASED 649
318 PRODUCT SUBSTITUTION ISSUE 648
319 PANCREATITIS 646
320 BLOOD CALCIUM DECREASED 644
321 DYSGEUSIA 639
322 NEUTROPHIL COUNT DECREASED 638
323 TINNITUS 629
324 HYPERKALAEMIA 626
325 APPLICATION SITE IRRITATION 623
326 DYSPHONIA 619
327 GASTRIC DISORDER 617
328 ANHEDONIA 615
329 RESPIRATORY TRACT INFECTION 613
330 TRANSAMINASES INCREASED 613
331 VIRAL INFECTION 611
332 DRY SKIN 609
333 TREATMENT NONCOMPLIANCE 609
334 SEROTONIN SYNDROME 608
335 DYSARTHRIA 607
336 INJECTION SITE ERYTHEMA 597
337 EYE PAIN 595
338 COLITIS 593
339 CRYING 589
340 DISORIENTATION 587
341 STAPHYLOCOCCAL INFECTION 587
342 RED BLOOD CELL COUNT DECREASED 586
343 POISONING 585
344 ELECTROCARDIOGRAM QT PROLONGED 580
345 MACULAR DEGENERATION 576
346 INFUSION SITE PAIN 574
347 LOCALISED INFECTION 572
348 PALLOR 571
349 DYSPNOEA EXERTIONAL 568
350 SKIN DISCOLOURATION 567
351 RESPIRATORY DEPRESSION 566
352 TOXIC EPIDERMAL NECROLYSIS 566
353 RASH PRURITIC 565
354 ASCITES 564
355 MULTIPLE DRUG OVERDOSE 563
356 THERAPY NON-RESPONDER 563
357 HYPERGLYCAEMIA 562
358 HEPATITIS 560
359 DIVERTICULITIS 558
360 HAEMATEMESIS 555
361 HAEMATURIA 554
362 MUSCLE SPASTICITY 554
363 PRODUCT ADMINISTRATION ERROR 553
364 PSORIASIS 551
365 PSYCHOTIC DISORDER 550
366 URINARY INCONTINENCE 550
367 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 548
368 LYMPHADENOPATHY 547
369 INTERSTITIAL LUNG DISEASE 546
370 URINARY RETENTION 546
371 DRUG WITHDRAWAL SYNDROME 545
372 KNEE ARTHROPLASTY 545
373 RENAL DISORDER 545
374 PNEUMONIA ASPIRATION 543
375 BLOOD CREATINE PHOSPHOKINASE INCREASED 542
376 DYSURIA 538
377 NEURALGIA 538
378 FUNGAL INFECTION 536
379 DRY EYE 535
380 MENTAL DISORDER 534
381 JAUNDICE 527
382 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 525
383 GASTRITIS 524
384 PRESCRIBED OVERDOSE 524
385 FLATULENCE 523
386 BRAIN OEDEMA 517
387 GAMMA-GLUTAMYLTRANSFERASE INCREASED 514
388 RED BLOOD CELL SEDIMENTATION RATE INCREASED 514
389 HYPOTHYROIDISM 512
390 BURSITIS 510
391 RESPIRATORY RATE INCREASED 509
392 STEVENS-JOHNSON SYNDROME 509
393 CROHN^S DISEASE 507
394 EXPOSURE TO TOXIC AGENT 505
395 BLOOD POTASSIUM DECREASED 504
396 PANIC ATTACK 504
397 HIP ARTHROPLASTY 503
398 POOR VENOUS ACCESS 500
399 NEPHROGENIC ANAEMIA 499
400 GASTRIC ULCER 494
401 PSORIATIC ARTHROPATHY 494
402 HAEMATOMA 492
403 HEPATIC FUNCTION ABNORMAL 490
404 APPLICATION SITE PAIN 486
405 POLLAKIURIA 486
406 ANGER 485
407 FEELING COLD 485
408 LIMB INJURY 484
409 TUBULOINTERSTITIAL NEPHRITIS 484
410 RHEUMATIC FEVER 483
411 ECONOMIC PROBLEM 482
412 MULTI-ORGAN FAILURE 482
413 LEUKOCYTOSIS 481
414 HAEMOPTYSIS 478
415 BONE DENSITY DECREASED 477
416 HEAD INJURY 476
417 SKIN EXFOLIATION 476
418 INFUSION SITE EXTRAVASATION 472
419 DISTURBANCE IN SOCIAL BEHAVIOUR 468
420 POOR QUALITY SLEEP 468
421 TOOTH DISORDER 466
422 RIB FRACTURE 464
423 DRUG LEVEL INCREASED 463
424 SUBSTANCE ABUSE 463
425 INTERVERTEBRAL DISC PROTRUSION 462
426 PAIN IN JAW 462
427 THERAPEUTIC RESPONSE SHORTENED 460
428 THERAPY CESSATION 459
429 ANGIOEDEMA 457
430 JOINT INJURY 457
431 PRODUCT DOSE OMISSION 455
432 ACUTE MYOCARDIAL INFARCTION 453
433 SURGERY 453
434 MULTIPLE SCLEROSIS 449
435 SKIN ULCER 447
436 THROAT TIGHTNESS 447
437 WITHDRAWAL SYNDROME 447
438 EYE DISORDER 445
439 PNEUMONITIS 443
440 BLOOD UREA INCREASED 442
441 SINUS TACHYCARDIA 442
442 ACNE 440
443 CREATININE RENAL CLEARANCE DECREASED 440
444 OSTEOPENIA 440
445 GAIT INABILITY 439
446 HEPATIC STEATOSIS 438
447 JOINT STIFFNESS 436
448 NEOPLASM MALIGNANT 436
449 SCIATICA 435
450 TRANSIENT ISCHAEMIC ATTACK 435
451 DRUG EXPOSURE DURING PREGNANCY 432
452 HIP FRACTURE 428
453 ATELECTASIS 426
454 CHOLESTASIS 426
455 PRESYNCOPE 425
456 CORONARY ARTERY DISEASE 424
457 INTESTINAL OBSTRUCTION 424
458 APHASIA 416
459 ACUTE RESPIRATORY DISTRESS SYNDROME 415
460 ULCER 414
461 SKIN DISORDER 413
462 CLOSTRIDIUM DIFFICILE INFECTION 411
463 PULMONARY FIBROSIS 410
464 CEREBRAL HAEMORRHAGE 409
465 LIVER FUNCTION TEST INCREASED 409
466 DIPLOPIA 408
467 FOOT FRACTURE 408
468 ANGINA PECTORIS 407
469 BLOOD PRESSURE DIASTOLIC INCREASED 407
470 KIDNEY INFECTION 407
471 MULTIPLE ORGAN DYSFUNCTION SYNDROME 407
472 PHOTOPHOBIA 407
473 BLOOD URINE PRESENT 405
474 LIMB DISCOMFORT 405
475 PULMONARY HYPERTENSION 405
476 MELAENA 404
477 JOINT RANGE OF MOTION DECREASED 403
478 SEDATION COMPLICATION 401
479 COLITIS ULCERATIVE 400
480 ACUTE RESPIRATORY FAILURE 399
481 DISEASE RECURRENCE 396
482 LIP SWELLING 396
483 INFUSION SITE SWELLING 395
484 HALLUCINATION, VISUAL 392
485 CYTOKINE RELEASE SYNDROME 390
486 HYPERSOMNIA 390
487 SWOLLEN JOINT COUNT INCREASED 389
488 MOUTH ULCERATION 388
489 DYSSTASIA 387
490 HAEMORRHOIDS 387
491 FEELING JITTERY 385
492 BREAST CANCER 384
493 SKIN LESION 382
494 TOOTHACHE 381
495 ACCIDENTAL EXPOSURE TO PRODUCT 380
496 PULMONARY CONGESTION 380
497 MUSCLE TWITCHING 379
498 SHOCK 378
499 PREMATURE BABY 375
500 EMOTIONAL DISORDER 374
501 HYPOPHAGIA 374
502 NIGHTMARE 373
503 RASH MACULO-PAPULAR 372
504 MOVEMENT DISORDER 369
505 INFUSION SITE ERYTHEMA 368
506 FEMUR FRACTURE 366
507 SWOLLEN TONGUE 365
508 TACHYPNOEA 363
509 HEPATIC NECROSIS 362
510 PREGNANCY 362
511 FEAR 360
512 HERNIA 358
513 LACTIC ACIDOSIS 358
514 GALLBLADDER DISORDER 357
515 BLOOD SODIUM DECREASED 356
516 SINUS DISORDER 356
517 EXPIRED PRODUCT ADMINISTERED 354
518 ORAL HERPES 354
519 MOOD SWINGS 353
520 BLINDNESS 350
521 DRUG EFFECT INCOMPLETE 350
522 PERICARDIAL EFFUSION 350
523 HEPATIC ENCEPHALOPATHY 348
524 CARDIOMEGALY 347
525 ECZEMA 347
526 EYE SWELLING 346
527 GASTROENTERITIS VIRAL 344
528 SKIN INFECTION 344
529 APPLICATION SITE RASH 343
530 BLOOD GLUCOSE DECREASED 343
531 SEASONAL ALLERGY 343
532 PHARYNGITIS 342
533 HEAD DISCOMFORT 340
534 RASH MACULAR 339
535 VASCULITIS 339
536 ALTERED STATE OF CONSCIOUSNESS 336
537 GLAUCOMA 335
538 IMMUNODEFICIENCY 335
539 MYDRIASIS 335
540 ORAL PAIN 333
541 PANCREATITIS ACUTE 333
542 BLOOD LACTATE DEHYDROGENASE INCREASED 332
543 INJECTION SITE REACTION 332
544 TOOTH INFECTION 331
545 LACRIMATION INCREASED 330
546 PRE-EXISTING CONDITION IMPROVED 330
547 ABSCESS 329
548 DEVICE DIFFICULT TO USE 328
549 MOOD ALTERED 328
550 SKIN LACERATION 326
551 RASH GENERALISED 322
552 WOUND INFECTION 322
553 BACTERIAL INFECTION 321
554 MUSCULOSKELETAL CHEST PAIN 321
555 ORAL CANDIDIASIS 321
556 GASTROENTERITIS 320
557 OSTEOMYELITIS 320
558 RESTLESS LEGS SYNDROME 320
559 INJECTION SITE SWELLING 317
560 OBESITY 317
561 POST PROCEDURAL COMPLICATION 317
562 PLASMA CELL MYELOMA 316
563 TOOTH LOSS 316
564 ACIDOSIS 315
565 CYANOSIS 315
566 MUCOSAL INFLAMMATION 315
567 NEUTROPHIL COUNT INCREASED 314
568 FAECES DISCOLOURED 313
569 MULTIPLE DRUG OVERDOSE INTENTIONAL 313
570 OSTEONECROSIS 309
571 NERVOUS SYSTEM DISORDER 307
572 RENAL TUBULAR NECROSIS 307
573 PROTEINURIA 306
574 ABORTION SPONTANEOUS 305
575 HIATUS HERNIA 305
576 CHROMATURIA 304
577 COORDINATION ABNORMAL 302
578 OCULAR HYPERAEMIA 302
579 ABDOMINAL PAIN LOWER 301
580 PULMONARY MASS 301
581 SPINAL OSTEOARTHRITIS 301
582 DEVICE ISSUE 299
583 DEMENTIA 297
584 PERIPHERAL COLDNESS 296
585 UPPER GASTROINTESTINAL HAEMORRHAGE 296
586 DISSEMINATED INTRAVASCULAR COAGULATION 294
587 PARANOIA 293
588 BLOOD POTASSIUM INCREASED 292
589 INJECTION SITE BRUISING 292
590 CONJUNCTIVITIS 291
591 PROTHROMBIN TIME PROLONGED 291
592 EOSINOPHILIA 290
593 EATING DISORDER 289
594 NODULE 289
595 PRURITUS GENERALISED 289
596 SINUS CONGESTION 289
597 GOUT 288
598 HYPOTHERMIA 288
599 DIABETES MELLITUS INADEQUATE CONTROL 287
600 CARDIOGENIC SHOCK 286
601 MUSCULOSKELETAL DISCOMFORT 286
602 BACTERAEMIA 284
603 DYSTONIA 284
604 DEVICE BREAKAGE 282
605 TENDERNESS 282
606 INJECTION SITE PRURITUS 281
607 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 280
608 HYPERPARATHYROIDISM SECONDARY 279
609 INTENTIONAL SELF-INJURY 279
610 SCAR 278
611 TOOTH ABSCESS 278
612 INCREASED APPETITE 277
613 SMALL INTESTINAL OBSTRUCTION 277
614 LABORATORY TEST ABNORMAL 276
615 VAGINAL HAEMORRHAGE 276
616 BONE DISORDER 275
617 FLUID OVERLOAD 274
618 MALNUTRITION 274
619 UPPER LIMB FRACTURE 274
620 POISONING DELIBERATE 273
621 DISABILITY 272
622 HYPOACUSIS 272
623 RED CELL DISTRIBUTION WIDTH INCREASED 272
624 CIRCULATORY COLLAPSE 270
625 LUNG INFECTION 267
626 RETCHING 267
627 VENTRICULAR TACHYCARDIA 267
628 COVID-19 PNEUMONIA 266
629 CHOLECYSTITIS CHRONIC 265
630 EYE IRRITATION 265
631 FACE OEDEMA 265
632 INJECTION SITE HAEMORRHAGE 265
633 MITRAL VALVE INCOMPETENCE 265
634 INTERVERTEBRAL DISC DEGENERATION 264
635 LOWER LIMB FRACTURE 264
636 CYST 263
637 DENTAL CARIES 263
638 HEMIPARESIS 263
639 SUSPECTED SUICIDE 263
640 CANDIDA INFECTION 262
641 GENERALISED OEDEMA 262
642 DEVICE RELATED INFECTION 261
643 ANKLE FRACTURE 260
644 EPILEPSY 259
645 SPINAL FRACTURE 259
646 MENTAL IMPAIRMENT 258
647 PLATELET COUNT INCREASED 258
648 BLOOD PRESSURE ABNORMAL 256
649 FOOT DEFORMITY 256
650 NEOPLASM PROGRESSION 256
651 WRIST FRACTURE 255
652 BASAL CELL CARCINOMA 254
653 ADRENAL INSUFFICIENCY 253
654 HEPATIC CYTOLYSIS 253
655 BLOOD ALBUMIN DECREASED 250
656 JOINT EFFUSION 250
657 RALES 250
658 EMPHYSEMA 249
659 EYE INFECTION 248
660 ABASIA 247
661 ACTIVITIES OF DAILY LIVING IMPAIRED 247
662 DRUG ERUPTION 247
663 PHARYNGITIS STREPTOCOCCAL 247
664 PNEUMOTHORAX 246
665 AGRANULOCYTOSIS 245
666 CLOSTRIDIUM DIFFICILE COLITIS 245
667 HEPATOCELLULAR INJURY 245
668 HEPATOMEGALY 245
669 ANAPHYLACTIC SHOCK 244
670 C-REACTIVE PROTEIN ABNORMAL 244
671 MUSCLE TIGHTNESS 244
672 MUSCULOSKELETAL DISORDER 244
673 LYMPHOPENIA 243
674 MUSCLE RIGIDITY 243
675 CARDIAC MURMUR 242
676 FEEDING DISORDER 242
677 HYPOCALCAEMIA 242
678 PRESCRIBED UNDERDOSE 242
679 TIC 242
680 OESOPHAGITIS 241
681 MASS 240
682 SPUTUM DISCOLOURED 240
683 CHOKING 239
684 CHOLECYSTITIS 239
685 DEAFNESS 239
686 EXTRA DOSE ADMINISTERED 238
687 IMPAIRED WORK ABILITY 238
688 INJECTION SITE EXTRAVASATION 238
689 APLASTIC ANAEMIA 236
690 COLD SWEAT 236
691 ARTERIOSCLEROSIS CORONARY ARTERY 235
692 HALLUCINATION, AUDITORY 235
693 MYOCLONUS 235
694 VISUAL ACUITY REDUCED 234
695 HYPERBILIRUBINAEMIA 233
696 WEIGHT FLUCTUATION 233
697 CYTOLYTIC HEPATITIS 232
698 EJECTION FRACTION DECREASED 232
699 APPENDICITIS 231
700 TOOTH FRACTURE 230
701 HYPOKINESIA 229
702 CEREBRAL INFARCTION 228
703 INFUSION SITE PRURITUS 228
704 LIVE BIRTH 228
705 DRUG SCREEN POSITIVE 227
706 FREQUENT BOWEL MOVEMENTS 227
707 INCORRECT PRODUCT ADMINISTRATION DURATION 226
708 ROTATOR CUFF SYNDROME 226
709 SNEEZING 225
710 MEDICATION OVERUSE HEADACHE 223
711 PROCEDURAL PAIN 223
712 TENDONITIS 223
713 LIGAMENT SPRAIN 222
714 ARTERIOSCLEROSIS 221
715 SPLENOMEGALY 219
716 THERAPY INTERRUPTED 219
717 DRUG USE DISORDER 218
718 FLANK PAIN 218
719 VENTRICULAR FIBRILLATION 218
720 CONCUSSION 217
721 THYROID DISORDER 217
722 DELUSION 216
723 BLOOD TEST ABNORMAL 215
724 HYPERCHOLESTEROLAEMIA 215
725 ASPHYXIA 214
726 PERITONITIS 214
727 DRUG LEVEL BELOW THERAPEUTIC 213
728 GENERALISED TONIC-CLONIC SEIZURE 213
729 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 213
730 JOINT DISLOCATION 213
731 NEPHROPATHY 212
732 PARAESTHESIA ORAL 212
733 DRUG LEVEL DECREASED 211
734 LARYNGITIS 211
735 MULTIPLE ALLERGIES 211
736 ASPIRATION 210
737 PETECHIAE 210
738 ABNORMAL DREAMS 209
739 MIDDLE INSOMNIA 209
740 BEDRIDDEN 208
741 CARDIOMYOPATHY 208
742 CARPAL TUNNEL SYNDROME 208
743 COELIAC DISEASE 208
744 SINUS BRADYCARDIA 208
745 AFFECT LABILITY 207
746 THIRST 207
747 GRIP STRENGTH DECREASED 206
748 HYPOMAGNESAEMIA 206
749 MANIA 206
750 PHARYNGEAL OEDEMA 206
751 RENAL CYST 205
752 UVEITIS 205
753 HYPERLIPIDAEMIA 204
754 ILEUS 204
755 POST-TRAUMATIC STRESS DISORDER 204
756 HAEMODIALYSIS 203
757 MYOCARDITIS 203
758 UROSEPSIS 203
759 GLOMERULAR FILTRATION RATE DECREASED 202
760 ISCHAEMIC STROKE 201
761 RASH PAPULAR 201
762 TRICUSPID VALVE INCOMPETENCE 201
763 URINE ABNORMALITY 201
764 VITAMIN D DEFICIENCY 201
765 BLOOD IRON DECREASED 200
766 EXOSTOSIS 200
767 MYOCARDIAL ISCHAEMIA 200
768 PYELONEPHRITIS 200
769 DEVICE ADHESION ISSUE 199
770 SUBDURAL HAEMATOMA 199
771 METASTASES TO BONE 198
772 PHARMACEUTICAL PRODUCT COMPLAINT 198
773 ATAXIA 197
774 ERYTHEMA MULTIFORME 197
775 HYPERCALCAEMIA 197
776 PHOTOSENSITIVITY REACTION 197
777 SENSORY DISTURBANCE 197
778 HAEMOLYSIS 196
779 LUNG INFILTRATION 196
780 SCOLIOSIS 196
781 APATHY 195
782 APHTHOUS ULCER 195
783 INFUSION SITE HAEMORRHAGE 194
784 INITIAL INSOMNIA 194
785 LUNG NEOPLASM MALIGNANT 194
786 ANOREXIA 193
787 CARDIOVASCULAR DISORDER 193
788 ECCHYMOSIS 193
789 SKIN IRRITATION 193
790 SKIN REACTION 193
791 RHINITIS 192
792 BONE MARROW FAILURE 190
793 EOSINOPHIL COUNT INCREASED 190
794 GRAND MAL CONVULSION 190
795 NERVE COMPRESSION 190
796 EYE PRURITUS 189
797 HEPATIC CIRRHOSIS 189
798 HEPATITIS ACUTE 189
799 NEUTROPENIC SEPSIS 189
800 SCHIZOPHRENIA 189
801 BONE LOSS 188
802 BRONCHOSPASM 188
803 FISTULA 188
804 PELVIC PAIN 188
805 SARS-COV-2 TEST POSITIVE 188
806 TEMPERATURE INTOLERANCE 188
807 APHONIA 187
808 BACK DISORDER 187
809 BLADDER DISORDER 187
810 BLOOD TRIGLYCERIDES INCREASED 187
811 BIPOLAR DISORDER 186
812 EXPOSURE VIA INGESTION 186
813 HYPOALBUMINAEMIA 186
814 METASTASES TO LIVER 186
815 DECUBITUS ULCER 185
816 ELECTROLYTE IMBALANCE 185
817 SUPRAVENTRICULAR TACHYCARDIA 185
818 INTENTIONAL MISUSE 184
819 SPINAL DISORDER 184
820 EDUCATIONAL PROBLEM 183
821 FOOD ALLERGY 183
822 MONOCYTE COUNT INCREASED 183
823 ANION GAP 182
824 DIVERTICULUM 182
825 FACIAL PARALYSIS 182
826 MULTIPLE FRACTURES 182
827 DERMATITIS CONTACT 181
828 RENAL FAILURE CHRONIC 181
829 SUDDEN DEATH 181
830 OVARIAN CYST 180
831 SKIN CANCER 180
832 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 179
833 APNOEA 179
834 ATRIAL FLUTTER 179
835 BLOOD COUNT ABNORMAL 179
836 HYPERTHERMIA 179
837 URINE OUTPUT DECREASED 179
838 GASTRIC HAEMORRHAGE 177
839 HAEMORRHAGE INTRACRANIAL 177
840 HEPATITIS CHOLESTATIC 177
841 HYPERAESTHESIA 177
842 REBOUND ACID HYPERSECRETION 177
843 VENTRICULAR EXTRASYSTOLES 177
844 AUTOIMMUNE DISORDER 176
845 HYPOAESTHESIA ORAL 176
846 INCONTINENCE 176
847 PSEUDOMONAS INFECTION 176
848 RENAL PAIN 176
849 ANALGESIC DRUG LEVEL INCREASED 175
850 CYTOMEGALOVIRUS INFECTION 175
851 IRON DEFICIENCY ANAEMIA 175
852 OSTEONECROSIS OF JAW 175
853 PURPURA 175
854 TUMOUR LYSIS SYNDROME 175
855 UPPER-AIRWAY COUGH SYNDROME 174
856 WALKING AID USER 174
857 ACCIDENTAL EXPOSURE 173
858 BLOOD MAGNESIUM DECREASED 173
859 OBSTRUCTIVE AIRWAYS DISORDER 173
860 RESPIRATORY TRACT CONGESTION 173
861 TARDIVE DYSKINESIA 173
862 ANAL FISSURE 172
863 PARALYSIS 172
864 POST PROCEDURAL INFECTION 172
865 EAR DISCOMFORT 171
866 MAJOR DEPRESSION 171
867 TROPONIN INCREASED 171
868 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 170
869 APPLICATION SITE SWELLING 170
870 CENTRAL NERVOUS SYSTEM LESION 170
871 SKIN BURNING SENSATION 170
872 WHITE BLOOD CELLS URINE POSITIVE 170
873 SPINAL COMPRESSION FRACTURE 169
874 BACK INJURY 168
875 FULL BLOOD COUNT DECREASED 168
876 DEFORMITY 167
877 EUPHORIC MOOD 167
878 MICTURITION URGENCY 167
879 ACUTE MYELOID LEUKAEMIA 166
880 CORONARY ARTERY OCCLUSION 166
881 DEVICE DISLOCATION 166
882 GINGIVAL BLEEDING 166
883 HYPERTHYROIDISM 166
884 IMPULSIVE BEHAVIOUR 165
885 LOCAL SWELLING 165
886 THINKING ABNORMAL 165
887 BRAIN INJURY 164
888 ESCHERICHIA INFECTION 162
889 FRACTURE 162
890 NERVE INJURY 162
891 ULCER HAEMORRHAGE 162
892 ARTHROPOD BITE 161
893 BRONCHIECTASIS 161
894 DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 161
895 GASTROINTESTINAL INFECTION 161
896 HYDRONEPHROSIS 161
897 HYPOPHOSPHATAEMIA 161
898 INFUSION SITE BRUISING 161
899 INCORRECT DRUG ADMINISTRATION RATE 160
900 MYOSITIS 160
901 SUBARACHNOID HAEMORRHAGE 160
902 JAUNDICE CHOLESTATIC 159
903 BODY TEMPERATURE FLUCTUATION 158
904 DECREASED ACTIVITY 158
905 DEPENDENCE 158
906 SOMNAMBULISM 158
907 ANAL INCONTINENCE 157
908 LACERATION 157
909 LYMPHOMA 157
910 NEUROLEPTIC MALIGNANT SYNDROME 157
911 BLOOD CREATININE DECREASED 156
912 DERMATITIS 156
913 EXTRAPYRAMIDAL DISORDER 156
914 CHRONIC SINUSITIS 155
915 DIALYSIS 155
916 IMMUNE SYSTEM DISORDER 155
917 PAIN OF SKIN 155
918 STATUS EPILEPTICUS 155
919 ACCIDENT 154
920 BLOOD LACTIC ACID INCREASED 154
921 INCREASED TENDENCY TO BRUISE 154
922 PREMATURE DELIVERY 154
923 DRUG EFFECT DELAYED 153
924 IRON DEFICIENCY 153
925 TENDON RUPTURE 153
926 BREAST MASS 152
927 ESCHERICHIA URINARY TRACT INFECTION 152
928 HAEMORRHAGIC STROKE 152
929 INTESTINAL PERFORATION 152
930 LYMPHOEDEMA 152
931 PNEUMONIA VIRAL 152
932 PROSTATE CANCER 152
933 PULMONARY HAEMORRHAGE 152
934 ANURIA 151
935 CHOLECYSTECTOMY 151
936 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 151
937 DEVICE MALFUNCTION 150
938 POST PROCEDURAL HAEMORRHAGE 150
939 PULMONARY ARTERIAL HYPERTENSION 150
940 APPLICATION SITE URTICARIA 149
941 DRY THROAT 149
942 LYMPHOCYTE PERCENTAGE DECREASED 149
943 QUALITY OF LIFE DECREASED 149
944 SPINAL PAIN 149
945 ATRIOVENTRICULAR BLOCK COMPLETE 148
946 DRUG ABUSER 148
947 HAEMOLYTIC ANAEMIA 148
948 PRODUCT PRESCRIBING ERROR 148
949 URINE ANALYSIS ABNORMAL 148
950 DRUG LEVEL ABOVE THERAPEUTIC 147
951 OLIGURIA 147
952 POSTOPERATIVE WOUND INFECTION 147
953 ABDOMINAL TENDERNESS 146
954 DIABETIC KETOACIDOSIS 146
955 FACIAL PAIN 146
956 IMPAIRED DRIVING ABILITY 146
957 TOXIC SKIN ERUPTION 146
958 VITAMIN D DECREASED 146
959 ELECTROCARDIOGRAM ABNORMAL 145
960 PNEUMONIA BACTERIAL 145
961 PRODUCT PHYSICAL ISSUE 145
962 TRANSFUSION 145
963 ERECTILE DYSFUNCTION 144
964 LIP DRY 144
965 MUSCLE ATROPHY 144
966 NAIL DISORDER 144
967 COLITIS ISCHAEMIC 143
968 INCORRECT ROUTE OF DRUG ADMINISTRATION 143
969 NEUROTOXICITY 143
970 SCAB 143
971 BLOOD PRESSURE SYSTOLIC DECREASED 142
972 DERMATITIS ALLERGIC 142
973 MENORRHAGIA 142
974 MOUTH HAEMORRHAGE 142
975 NEPHROPATHY TOXIC 142
976 PRODUCT STORAGE ERROR 142
977 DRUG TOLERANCE DECREASED 141
978 GROIN PAIN 141
979 NO THERAPEUTIC RESPONSE 141
980 SCRATCH 141
981 SOFT TISSUE DISORDER 141
982 TONGUE DISORDER 141
983 EAR PRURITUS 140
984 EYELID OEDEMA 140
985 HYPOVOLAEMIA 140
986 INJECTION SITE MASS 140
987 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 140
988 FAILURE TO THRIVE 139
989 HAEMODYNAMIC INSTABILITY 139
990 HUNGER 139
991 LIPASE INCREASED 139
992 LOGORRHOEA 139
993 MOTOR DYSFUNCTION 139
994 MYELODYSPLASTIC SYNDROME 139
995 NEEDLE ISSUE 139
996 NEUTROPHIL PERCENTAGE INCREASED 139
997 PULMONARY THROMBOSIS 139
998 SKIN FISSURES 139
999 AGEUSIA 138